Gene Therapy Market is projected to grow at an annualized rate of 45%, till 2030

Chandigarh, Haryana, IN ₹ 94,209.00

2 years ago ID #8762


Presently, there are more than 10 approved gene therapies; over 465 product candidates are being evaluated for the treatment of a variety of disease indications Encouraging clinical results across various metabolic, hematological and ophthalmic disorders have inspired research groups across the world to focus their efforts on the development of novel gene editing therapies. In fact, the gene therapy pipeline has evolved significantly over the past few years, with three products being approved in 2019 alone; namely Beperminogene perplasmid (AnGes), ZOLGENSMA® (AveXis) and ZYNTEGLO™ (bluebird bio). Further, there are multiple pipeline candidates in mid to late-stage (phase II and above) trials that are anticipated to enter the market over the next 5-10 years. The USD 11.6 billion (by 2030) financial opportunity within the Gene Therapy Market has been analyzed across the following segments:  Key therapeutic areas • Autoimmune disorders • Cardiovascular diseases • Genetic disorders • Hematological disorders • Metabolic disorders • Ophthalmic disorders • Oncological disorders • Others Type of vector • Adeno associated virus • Adenovirus • Herpes simplex virus type 1 • Lentivirus • Plasmid DNA • Retrovirus • Vaccinia Virus Type of therapy • Ex vivo • In vivo Type of gene modification • Gene augmentation • Immunotherapy • Oncolytic therapy • Others Route of administration • Intraarticular • Intracerebellar • Intramuscular • Intradermal • Intravenous • Intravitreal • Intravesical • Subretinal • Others Key geographical regions • North America • Europe • Asia-Pacific Get Detailed Sample Report: The Gene Therapy Market (3rd Edition), 2019-2030 report features the following companies, which we identified to be key players in this domain: • Advantagene • Advaxis • BioMarin • bluebird bio • FKD Therapies • Freeline Therapeutics • GenSight Biologics • Gradalis • Inovio Pharmaceuticals • Marsala Biotech • Orchard Therapeutics • Pfizer • Sarepta Therapeutics • Spark Therapeutics • Tocagen • Transgene • uniQure Biopharma • VBL Therapeutics • ViroMed


Result 0 votes
Share by email Share on Facebook Share on Twitter Share on Google+ Share on LinkedIn Pin on Pinterest

Comments 0

No comments has been added yet